Proton-Antiproton Annihilation in Baryonium

A possible interpretation of the near-threshold enhancement in the $(p\bar{p})$-mass spectrum in $J/\psi{\to}\gamma p{\bar p}$ is the of existence of a narrow baryonium resonance X(1860). Mesonic decays of the $(p\bar{p})$-bound state X(1860) due to the nucleon-antinucleon annihilation are investigated in this paper. Mesonic coherent states with fixed $G$-parity and $P$-parity have been constructed . The Amado-Cannata-Dedoder-Locher-Shao formulation(Phys Rev Lett. {\bf 72}, 970 (1994)) is extended to the decays of the X(1860). By this method, the branch-fraction ratios of $Br(X\to \eta 4\pi)$, $Br(X\to \eta 2\pi)$ and $Br(X\to 3\eta)$ are calculated. It is shown that if the X(1860) is a bound state of $(p\bar{p})$, the decay channel ($X\to \eta 4\pi)$ is favored over $(X\to \eta 2\pi)$. In this way, we develop criteria for distinguishing the baryonium interpretation for the near-threshold enhancement effects in $(p\bar{p})$-mass spectrum in $J/\psi{\to}\gamma p{\bar p}$ from other possibilities. Experimental checks are expected. An intuitive picture for our results is discussed.Comment: 19 pages, 3 figure

Multi-Receiver Quantum Dense Coding with Non-Symmetric Quantum Channel

A two-receiver quantum dense coding scheme and an $N$-receiver quantum dense coding scheme, in the case of non-symmetric Hilbert spaces of the particles of the quantum channel, are investigated in this paper. A sender can send his messages to many receivers simultaneously. The scheme can be applied to quantum secret sharing and controlled quantum dense coding.Comment: To appear in Journal of the Korean Physical Societ

Patient-controlled epidural Levobupicvacaine with or without Fentanyl for post-cesarean section pain relief

Purpose. The purpose of this study was to compare the analgesic properties of levobupivacaine with or without fentanyl for patient-controlled epidural analgesia after Cesarean section in a randomized, double-blinded study. Methods. We enrolled American Society of Anesthesiologists class I/II, full-term pregnant women at National Taiwan University Hospital who received patient-controlled epidural analgesia after Cesarean section between 2009 and 2010. Eighty women were randomly assigned into two groups. In group A, the 40 subjects received drug solutions made of 0.6 mg/ml levobupivacaine plus 2 mcg/ml fentanyl, and in group B the 40 subjects received 1 mg/ml levobupivacaine. Maintenance was self-administered boluses and a continuous background infusion. Results. There were no significant differences in the resting and dynamic pain scales and total volume of drug used between the two groups. Patient satisfaction was good in both groups. Conclusion. Our study showed that pure epidural levobupivacaine can provide comparative analgesic properties to the levobupivacaine-fentanyl combination after Cesarean section. Pure levobupivacaine may serve as an alternative pain control regimen to avoid opioid-related adverse events in parturients

Effect of ketoconazole-mediated CYP3A4 inhibition on clinical pharmacokinetics of panobinostat (LBH589), an orally active histone deacetylase inhibitor

Purpose: Panobinostat is partly metabolized by CYP3A4 in vitro. This study evaluated the effect of a potent CYP3A inhibitor, ketoconazole, on the pharmacokinetics and safety of panobinostat. Methods: Patients received a single panobinostat oral dose on day 1, followed by 4 days wash-out period. On days 5-9, ketoconazole was administered. On day 8, a single panobinostat dose was co-administered with ketoconazole. Panobinostat was administered as single agent three times a week on day 15 and onward. Results: In the presence of ketoconazole, there was 1.6- and 1.8-fold increase in Cmaxand AUC of panobinostat, respectively. No substantial change in Tmaxor half-life was observed. No difference in panobinostat-pharmacokinetics between patients carrying CYP3A5*1/*3 and CYP3A5*3/*3 alleles was observed. Most frequently reported adverse events were gastrointestinal related. Patients had asymptomatic hypophosphatemia (64%), and urine analysis suggested renal phosphate wasting. Conclusions: Co-administration of panobinostat with CYP3A inhibitors is feasible as the observed increase in panobinostat PK parameters was not considered clinically relevant. Considering the variability in exposure following enzyme inhibition and the fact that chronic dosing of panobinostat was not studied with CYP3A inhibitors, close monitoring of panobinostat-related adverse events is necessary

Triple negative breast carcinoma is a prognostic factor in Taiwanese women

© 2009 Lin et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution Licens

Elliptic flow of electrons from heavy-flavor hadron decays in Au+Au collisions at sNN=\sqrt{s_{\rm NN}} = 200, 62.4, and 39 GeV

We present measurements of elliptic flow ($v_2$) of electrons from the decays of heavy-flavor hadrons ($e_{HF}$) by the STAR experiment. For Au+Au collisions at $\sqrt{s_{\rm NN}} =$ 200 GeV we report $v_2$, for transverse momentum ($p_T$) between 0.2 and 7 GeV/c using three methods: the event plane method ($v_{2}${EP}), two-particle correlations ($v_2${2}), and four-particle correlations ($v_2${4}). For Au+Au collisions at $\sqrt{s_{\rm NN}}$ = 62.4 and 39 GeV we report $v_2${2} for $p_T< 2$ GeV/c. $v_2${2} and $v_2${4} are non-zero at low and intermediate $p_T$ at 200 GeV, and $v_2${2} is consistent with zero at low $p_T$ at other energies. The $v_2${2} at the two lower beam energies is systematically lower than at $\sqrt{s_{\rm NN}} =$ 200 GeV for $p_T < 1$ GeV/c. This difference may suggest that charm quarks interact less strongly with the surrounding nuclear matter at those two lower energies compared to $\sqrt{s_{\rm NN}} = 200$ GeV.Comment: Version accepted by PR